Atlas Trials

Long-term Study of CS-3150 as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patients With Essential Hypertension

Clinical trial NCT02722265 · COMPLETED

Trial details

NCT number
NCT02722265
Sponsor
Daiichi Sankyo Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Essential Hypertension
Start date
2016-03-01
Primary completion
2017-07-08
Enrollment
368

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.